The prequalification designation indicates that the medicine meets international standards of quality, safety and efficacy,” the WHO said in a statement |Image used for representational purpose only | Photo Credit: AFP
The World Health Organization announced Friday that it had given prequalification approval to a malaria treatment for newborns and infants for the first time.
Artemether-lumefantrine is the first antimalarial formulation designed specifically for the youngest victims of the mosquito-borne disease.
Published - April 25, 2026 02:54 pm IST
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。
